Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$474,139
-$8,142 QoQ
Shares Held
3,868
-46.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#215
of 341 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $413,155,276 across 381 Biotechnology names. PTGX ranks #181 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in PTGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,139 | 3,868 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $482,281 | 7,260 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $405,239 | 7,332 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $689,468 | 14,257 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $260,318 | 6,744 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $666,045 | 14,801 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $269,198 | 16,139 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $141,197 | 12,942 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $327,286 | 38,824 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $99,847 | 12,623 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||